Table 2.
Fluorescent substrate | % Transport (mean ± SD) | Transport efficiency |
---|---|---|
TMR Chloride | 121 ± 5 | Full transport (>75%) |
BD-Verapamil | 116 ± 4 | |
BD-EDA | 108 ± 9 | |
TMRE | 100 ± 3 | |
DiOC | 94 ± 3 | |
BD-Forskolin | 93 ± 12 | |
Calcein-AM | 88 ± 15 | |
Cell Tracker Orange | 83 ± 6 | |
SYTO 13 | 82 ± 5 | |
Daunorubicin | 79 ± 11 | |
BD-Prazosin | 71 ± 7 | Partial transport (30–75%) |
LDS-751 | 70 ± 11 | |
Rhodamine 123 | 66 ± 5 | |
Dihydrorhodamine | 63 ± 12 | |
BD-Paclitaxel | 29 ± 15 | Little to no transport (<30%) |
NBD-CsA | 22 ± 9 | |
BD-Vinblastine | No detectable transport |
Substrates were grouped into three categories based on their transport level when compared to WT; Full transport (>75%), Partial transport (30–75%), and little to no transport (<30%). The transport assays were carried out as described in the Materials and Methods section, and mean ± SD values are from four or more independent experiments. TMR, tetramethylrhosamine, BD-EDA, Bodipy-FL-4,4-difluoro-5,7-dimethyl-4-bora-3a,4a–diaza-s-indacene-3-propionyl ethylenediamine, hydrochloride. TMRE, tetramethylrhodamine ethyl ester perchlorate. DiOC2, 3,3’-Diethyloxancarbocyanine iodide. Cell tracker orange CMTMR, (5-(and-6)-(((4-chloromethy)benzyol)amino)tetramethylrhodamine). LDS-751, quinolinium, 6-(dimethylamino)-2-[4-[4-(dimethylamino)phenyl]-1-ethyl, perchlorate. NBD-CsA, [N-ε(4-nitrobenzofurzan-7-yl)-d-lys cyclosporine A.